Holen Sie sich die Stockscreener-App
3.045
1.94%
-0.045
Schlusskurs vom Vortag:
$3.09
Offen:
$3.095
24-Stunden-Volumen:
19,351
Relative Volume:
0.09
Marktkapitalisierung:
$45.32M
Einnahmen:
$37.79M
Nettoeinkommen (Verlust:
$-10.38M
KGV:
-4.1712
EPS:
-0.73
Netto-Cashflow:
$-1.00M
1W Leistung:
-13.43%
1M Leistung:
-21.91%
6M Leistung:
-11.92%
1J Leistung:
-44.81%
1-Tages-Spanne:
$3.03
$3.14
1-Wochen-Bereich:
$3.02
$3.552
52-Wochen-Spanne:
$1.85
$6.265
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Firmenname
Cumberland Pharmaceuticals Inc
Sektor
Telefon
615-255-0068
Adresse
1600 WEST END AVENUE, NASHVILLE,, TN
Compare CPIX vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.03 | 46.22M | 37.79M | -10.38M | -1.00M | -0.73 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.83 | 56.14B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
114.87 | 48.74B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
10.06 | 44.85B | 14.54B | 2.22B | 2.58B | 0.4879 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
28.80 | 34.12B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
535.74 | 23.35B | 3.13B | 1.27B | 1.12B | 26.39 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2012-11-12 | Bestätigt | UBS | Neutral |
| 2011-02-01 | Bestätigt | UBS | Neutral |
| 2010-12-16 | Herabstufung | UBS | Buy → Neutral |
| 2010-08-17 | Herabstufung | Jefferies | Buy → Hold |
| 2010-08-17 | Bestätigt | Morgan Joseph | Buy |
| 2010-08-17 | Bestätigt | UBS | Buy |
| 2010-05-14 | Bestätigt | Morgan Joseph | Buy |
Alle ansehen
Cumberland Pharmaceuticals Inc Aktie (CPIX) Neueste Nachrichten
Aug Macro: What is the dividend yield of Cumberland Pharmaceuticals Inc2026 Summary & Community Verified Trade Signals - baoquankhu1.vn
Trend Report: Can Cumberland Pharmaceuticals Inc beat the S P 500Trade Exit Summary & High Conviction Buy Zone Picks - baoquankhu1.vn
Dilated Cardiomyopathy Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Bristol Myers Squibb, Berlin Cures, Cumberland Pharma, Vericel Corp, Corimmun GmbH, Pfizer, Constant Therapeut - Barchart.com
Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales - Yahoo Finance
Cumberland Pharmaceuticals Inc. Business Overview, Product Portfolio, Growth Strategy, and International Partnerships 2025 - Minichart
Cumberland Pharmaceuticals 2025 10-K — Revenue $44.5M, Net loss $2.9M - TradingView
Swing Trade: What is the dividend yield of Cumberland Pharmaceuticals IncPortfolio Risk Summary & Low Risk High Reward Trade Ideas - baoquankhu1.vn
How resilient is Cumberland Pharmaceuticals Inc. stock in market downturns2026 Rallies & Low Volatility Stock Recommendations - Naître et grandir
Risk Recap: Will Cumberland Pharmaceuticals Inc announce a stock splitJuly 2025 Catalysts & Short-Term High Return Ideas - baoquankhu1.vn
Aug Highlights: Can Cumberland Pharmaceuticals Inc reach all time highs this year - baoquankhu1.vn
Momentum Shift: Is Cumberland Pharmaceuticals Inc in a bullish channelTrade Entry Summary & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Pale Fire Capital Bets Big on Healthcare With a 2.07 Million Share Baxter International (BAX) Investment - AOL.com
1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth - AOL.com
Phibro Animal Health President and CEO Sells 72k Shares After Strong Q2 2026 Performance - AOL.com
CPIX SEC FilingsCumberland Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing - AOL.com
Disc Medicine CFO Sells $720k Worth of Shares Amid FDA Rejection - AOL.com
CPIX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Cumberland Pharmaceuticals Reports 31% Q4 2025 Revenue Growth, Expands Internationally, and Achieves Key Clinical and Financial Milestones - Minichart
Cumberland (CPIX) Q4 2025 Earnings Call Transcript - AOL.com
Cumberland: Fourth Quarter Financial Results Overview - Bitget
Earnings call transcript: Cumberland Pharmaceuticals Q4 2025 sees revenue surge - Investing.com
Cumberland Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
Cumberland: Q4 Earnings Snapshot - GreenevilleSun.com
Cumberland Pharmaceuticals 2025 revenue rises - TradingView
CUMBERLAND PHARMACEUTICALS REPORTS 31% FOURTH QUARTER 2025 REVENUE GROWTH - PR Newswire
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale - AOL.com
Joint U.S. Commercialization of RedHill's Talicia® Commences - marketscreener.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
H. pylori drug Talicia rolls out in U.S. as infection hits 35% of adults - Stock Titan
Cumberland Pharma schedules Mar. 3 call on 2025 results and company update - Stock Titan
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE 2025 ANNUAL FINANCIAL RESULTS & COMPANY UPDATE - Yahoo Finance
Volume Report: Why is Cumberland Pharmaceuticals Inc stock going upWeekly Trend Recap & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge - AOL.com
Merger Talk: Can Cumberland Pharmaceuticals Inc reach all time highs this yearPrice Action & Weekly Top Performers Watchlists - baoquankhu1.vn
Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress - AOL.com
Why is Cumberland Pharmaceuticals Inc. stock going upCPI Data & AI Enhanced Trading Signals - mfd.ru
Why ImmunityBio Stock Is Soaring Today - AOL.com
Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead - Intellectia AI
Why Did Compass Pathways Stock Rocket Higher Today? - AOL.com
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above 200 Day Moving AverageShould You Sell? - MarketBeat
Will Cumberland Pharmaceuticals Inc. announce a stock splitQuarterly Market Review & Accurate Trade Setup Notifications - mfd.ru
Momentum Shift: Is Cumberland Pharmaceuticals Inc stock a top performer YTDJuly 2025 Short Interest & Safe Entry Point Alerts - baoquankhu1.vn
Portfolio Shifts: What is the dividend yield of Cumberland Pharmaceuticals IncEarnings Risk Report & Capital Protection Trading Alerts - baoquankhu1.vn
What is the dividend yield of Cumberland Pharmaceuticals Inc.Quarterly Performance Summary & High Win Rate Trade Tips - mfd.ru
Why Cumberland Pharmaceuticals Inc. stock is favored by top institutionsRisk Management & Intraday High Probability Alerts - mfd.ru
Little Excitement Around Cumberland Pharmaceuticals Inc.'s (NASDAQ:CPIX) Revenues As Shares Take 31% Pounding - simplywall.st
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Passes Above 200-Day Moving AverageHere's Why - MarketBeat
Bristol Myers Just Crushed Earnings, and the Real Catalyst Hasn’t Even Hit Yet - AOL.com
FDA fast tracks Dyscorban for treating heart problems in Duchenne - Muscular Dystrophy News
Ideas Watch: Why is Cumberland Pharmaceuticals Inc stock going upEarnings Miss & Long Hold Capital Preservation Tips - baoquankhu1.vn
Finanzdaten der Cumberland Pharmaceuticals Inc-Aktie (CPIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.81%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):